ResMed Inc (RMD) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.

Total Revenue Chart for ResMed Inc

ResMed Inc (RMD) revenue for FY2026 was USD 5.7B, a 9.9% change from FY2025. ResMed Inc's revenue grew from USD 7.7M in 1993 to USD 5.7B in 2026 (73321.3% over 33 years). Earnings per share grew from USD 0.17 in 2000 to USD 9.51 in 2025 (5426.8%). Revenue compound annual growth rate: 5-year CAGR of 12.1%, 10-year CAGR of 11.9%, 20-year CAGR of 11.8%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$32.38B
Implied Share Price
$224.46
Enterprise Value
$31.74B
Revenue (TTM)
$5.65B
EBITDA
$2.10B
Profit Margin
26.95%
Trailing P/E
21.50
Forward P/E
18.69
Price/Book (MRQ)
4.92
Price/Sales (TTM)
5.73
EV/EBITDA
14.74
EV/Revenue
5.61
Dividend Yield
1.06%
Book Value
$45.51
Free Cash Flow (FY2026)
$1.65B
Free Cash Flow Yield
5.09%

Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.